Table 3.

Relative changes in total tumor burden at 6-week posttherapy

SLD (%)SBI (%)SVOL (%)
Interpretation modeRadiologistMedianIQRMedianIQRMedianIQR
1. Target lesion selection and measurement1−21(−28 to −6)−35(−52 to −8)−45(−68 to −12)
2−15(−30 to −5)−25(−54 to −6)−41(−68 to −13)
3−21(−32 to −5)−33(−52 to −7)−44(−69 to −7)
Within-patient variability±11%±19%±−22%
2. Target lesion measurement only1−21(−28 to −6)−35(−52 to −8)−45(−68 to −12)
2−24(−32 to −6)−39(−53 to −16)−46(−70 to −20)
3−20(−34 to −6)−36(−52 to −10)−41(−69 to −19)
Within-patient variability±8%±14%±−12%